Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda

British Journal of Dermatology

Volumn 171, Issue 6, 2014, Pages 1595-1596

  Aguilera, P ^a   Laguno, M ^a   To Figueras, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BOCEPREVIR; CHLOROQUINE; DIDANOSINE; NEVIRAPINE; PEGINTERFERON; PORPHYRIN; RIBAVIRIN; STAVUDINE; VIRUS RNA; ANTIVIRUS AGENT; N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE; PROLINE;

ADULT; BLISTER; CASE REPORT; CHRONIC HEPATITIS; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LOW DRUG DOSE; MALE; MIDDLE AGED; MIXED INFECTION; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; REMISSION; SKIN DEFECT; SKIN EROSION; SKIN FRAGILITY; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; COMPLICATION; DRUG COMBINATION; HEPATITIS C, CHRONIC;

ANTIVIRAL AGENTS; COINFECTION; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; PROLINE; REMISSION INDUCTION;

EID: 84919486295     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13376     Document Type: Letter

References (8)

1. Ryan Caballes F, Sendi H, Bonkovsky HL,. Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int 2012; 32: 880-93.
2. Elder GH,. Porphyria cutanea tarda. Semin Liver Dis 1998; 18: 67-75.
3. Muñoz-Santos C, Guilabert A, Moreno N, et al,. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients. Medicine 2010; 89: 69-74.
4. Moore C, Levitsky J,. The current state and future prospects of chronic hepatitis C virus infection treatment. Curr Infect Dis Rep 2014; 16: 413.
5. Furuta M, Kaito M, Gabazza E, et al,. Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels. J Gastroenterol 2000; 35: 60-2.
6. Marinho RT, Vitor S, Velosa J,. Benefits of curing hepatitis C infection. J Gastrointestin Liver Dis 2014; 23: 85-90.
7. Pawlotsky JM,. New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development. Semin Liver Dis 2014; 34: 22-9.
8. Fargion S, Piperno A, Cappellini MD, et al,. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-6.